This finding was supported in human patients with multiple sclerosis, rheumatoid arthritis, and psoriasis, in whom increased levels of IL-17 and IL-23 were observed (Ziolkowska et al., 2000; Cho et al., 2004; Vaknin-Dembinsky et al., 2006). This evidence concerns the gene IL17A and psoriasis.